Avgil Tsadok, Meytal <br/><br/>
Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.  [electronic resource] 

 -  Circulation. Cardiovascular quality and outcomes  Nov 2015 
 - 593-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7705 
<br/><br/><label>Standard No.: </label>10.1161/CIRCOUTCOMES.114.001398  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antithrombins--adverse effects<br/>Atrial Fibrillation--complications<br/>Dabigatran--adverse effects<br/>Databases, Factual<br/>Drug Prescriptions<br/>Drug Utilization Review<br/>Female<br/>Health Knowledge, Attitudes, Practice<br/>Healthcare Disparities<br/>Hemorrhage--chemically induced<br/>Humans<br/>Logistic Models<br/>Male<br/>Medication Adherence<br/>Multivariate Analysis<br/>Odds Ratio<br/>Propensity Score<br/>Proportional Hazards Models<br/>Quebec<br/>Risk Assessment<br/>Risk Factors<br/>Sex Factors<br/>Stroke--diagnosis<br/>Treatment Outcome<br/>Warfarin--adverse effects